Pacira BioSciences, Inc.
Ticker: 1396814
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 177.38-1.2% | 179.52-0.9% | 181.10+7.2% | 168.92+0.2% | 168.57-5.3% | 178.02+6.5% | 167.12+1.9% | 163.93 |
| Total Income | 177.38-1.2% | 179.52-0.9% | 181.10+7.2% | 168.92+0.2% | 168.57-5.3% | 178.02+6.5% | 167.12+1.9% | 163.93 |
| EXPENSES | ||||||||
| Expenditure | 170.47-1.5% | 173.15+0.3% | 172.60+3.4% | 166.93-45.8% | 308.10+105.7% | 149.78-2.7% | 153.91+5.3% | 146.21 |
| Tax | 2.08-49.1% | 4.09+40.1% | 2.92-24.9% | 3.89-15.6% | 4.61-74.0% | 17.70+279.8% | 4.66-18.8% | 5.74 |
| PROFIT | ||||||||
| PBT | 5.00-47.5% | 9.52+593.3% | -1.93-122.2% | 8.71+106.3% | -138.86-479.6% | 36.58+168.2% | 13.64-17.8% | 16.60 |
| Net Profit | 2.92-46.2% | 5.43+212.0% | -4.85-200.8% | 4.81+103.4% | -143.47-859.5% | 18.89+110.4% | 8.98-17.3% | 10.86 |
| KEY METRICS | ||||||||
| OPM % | 3.89%+0.35pp | 3.54%-1.15pp | 4.69%+3.51pp | 1.18%+83.95pp | -82.77%-98.63pp | 15.86%+7.96pp | 7.91%-2.90pp | 10.81% |
| NPM % | 1.64%-1.38pp | 3.03%+5.70pp | -2.68%-5.53pp | 2.85%+87.95pp | -85.11%-95.71pp | 10.61%+5.24pp | 5.37%-1.25pp | 6.62% |
| EPS | 0.07-41.7% | 0.12+209.1% | -0.11-210.0% | 0.10+103.2% | -3.11-858.5% | 0.41+115.8% | 0.19-17.4% | 0.23 |
Corporate Events
Board MeetingPCRX
20269Jun
Board Meeting
Annual Meeting of Stockholders to elect directors amidst a p…
SEC Filing ↗